187
Participants
Start Date
November 4, 2020
Primary Completion Date
February 4, 2022
Study Completion Date
February 4, 2022
LY900014
Administered SC
Insulin Glargine
Administered SC
Research NYC, Inc, New York
Suny Health Science Center at Syracuse, Syracuse
Manassas Clinical Research Center, Manassas
Endocrine and Metabolic Consultants, Rockville
Maryland Cardiovascular Specialists, Baltimore
Burke Internal Medicine and Research, Burke
Cataret Medical Group, Morehead City
Atlanta Diabetes Associates, Atlanta
East Coast Institute for Research at The Jones Center, Macon
Encore Medical Research, Hollywood
Metabolic Research Institute, Inc., West Palm Beach
Sun Coast Clinical Research, Inc, New Port Richey
Iowa Diabetes and Endocrinology Research Center, West Des Moines
Central Illinois Diabetes and Clinical Research a Division of Prairie Education and Research Cooperative, Springfield
Intend Research, LLC, Norman
Dallas Diabetes Research Center, Dallas
Biopharma Informatic, LLC, Houston
Endocrine Ips, Pllc, Houston
Consano Clinical Research, LLC, Shavano Park
Texas Diabetes & Endocrinology, P.A., Austin
Rocky Mountain Clinical Research, Idaho Falls
Palm Research Center Tenaya, Las Vegas
Palm Research Center Tenaya, Las Vegas
AMCR Institute, Escondido
University Clinical Investigators, Inc., Tustin
Coastal Metabolic Research Centre, Ventura
Valley Endocrine, Fresno, Fresno
John Muir Physician Network Clinical Research Center, Concord
Rainier Clinical Research Center, Renton
CMR of Greater New Haven, Hamden
Manati Center for Clinical Research Inc, Manatí
Advanced Clinical Research, LLC, Bayamón
Eli Lilly and Company
INDUSTRY